Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3684034010 | Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3684036012 | Methyltestosterone 5 mg and pemoline 10 mg and yohimbine 5 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Methyltestosterone and pemoline and yohimbine only product in oral dose form | true | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Methyltestosterone | true | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Yohimbine | true | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Methyltestosterone | true | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Yohimbine | true | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing methyltestosterone and pemoline and yohimbine (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Hormone | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Pemoline (substance) | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Yohimbine | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Methyltestosterone | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Stimulant (substance) | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Alpha-2 adrenergic receptor antagonist | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Anabolic androgenic steroid | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Capsule | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing testosterone in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Oral capsule | true | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Pemoline (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Pemoline (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | dix | false | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | cinq | false | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | cinq | false | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Yohimbine | false | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | cinq | false | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Yohimbine | false | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Yohimbine | false | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Methyltestosterone | false | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Methyltestosterone | false | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Pemoline (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | dix | false | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Pemoline (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Methyltestosterone | false | Inferred relationship | Some | 3 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Yohimbine | false | Inferred relationship | Some | 1 | |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Methyltestosterone- and pemoline- and yohimbine-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | trois | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets